Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;37:1423-1428

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tambascia, R. C.
Right arrow Articles by Franchini, K. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tambascia, R. C.
Right arrow Articles by Franchini, K. G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Other myocardial biology
Right arrow ACE/Angiotension receptors
Right arrow Gene regulation

(Hypertension. 2001;37:1423.)
© 2001 American Heart Association, Inc.


Scientific Contributions

Expression and Distribution of NOS1 and NOS3 in the Myocardium of Angiotensin II–Infused Rats

Rosa C. Tambascia; Priscila M. Fonseca; Patrícia D. C. Corat; Heitor Moreno, Jr; Mario J. A. Saad; Kleber G. Franchini

From the Department of Internal Medicine, School of Medicine, State University of Campinas (UNICAMP), Campinas, SP, Brazil.

Correspondence to Kleber G. Franchini, MD, Departamento de Clínica Médica, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Cidade Universitária "Zefferino Vaz," 13081-970 Campinas, SP, Brasil. E-mail franchin{at}obelix.unicamp.br

Abstract—Studies have indicated a complex functional interaction between angiotensin (Ang) II and NO in the heart. The purpose of the present study was to examine the protein expression and tissue distribution of NO synthases 1 (NOS1) and 3 (NOS3) in the myocardium of rats that underwent continuous infusion of Ang II at 2 different rates (10 and 40 ng · kg-1 · min-1) for 6 days. Mean arterial pressure increased by {approx}15 mm Hg in rats infused with Ang II at 40 ng · kg-1 · min-1, but it remained close to the values observed in saline-infused rats ({approx}110 mm Hg) when Ang II was infused at 10 ng · kg-1 · min-1. The protein expression of a 160-kDa NOS1 and a 135-kDa NOS3 were found to increase ({approx}200%) in the myocardium of rats infused with both subpressor and pressor doses of Ang II. Immunohistochemistry studies showed that NOS1 and NOS3 are differentially expressed in myocardial cells. NOS1 was detected in cardiac myocytes and in smooth muscle cells of small and large coronary arteries, whereas NOS3 was detected in the endothelium and in perivascular and interstitial tissues, but NOS3 was not detected in cardiac or smooth muscle cells. Ang II infusion enhanced the tissue immunoreactivity of both isoforms in their specific locations but did not change the distribution throughout the myocardium. Myocardium staining with anti–angiotensin type 1 (AT1) receptor antibody indicated that AT1 receptor is expressed in cardiac myocytes, coronary smooth muscle cells, and interstitial and perivascular tissues. Ang II infusion did not change the protein expression and distribution of AT1 receptor in the myocardium. These results indicate that long-term increases in the circulating levels of Ang II modulate the protein expression of NOS1 and NOS3 and, consequently, the function of the local myocardial NO system.


Key Words: angiotensin II • nitric oxide • nitric oxide synthase • heart • myocardium




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. S. A. Capettini, S. F. Cortes, M. A. Gomes, G. A. B. Silva, J. L. Pesquero, M. J. Lopes, M. M. Teixeira, and V. S. Lemos
Neuronal nitric oxide synthase-derived hydrogen peroxide is a major endothelium-dependent relaxing factor
Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2503 - H2511.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Loyer, P. Oliviero, T. Damy, E. Robidel, F. Marotte, C. Heymes, and J.-L. Samuel
Effects of sex differences on constitutive nitric oxide synthase expression and activity in response to pressure overload in rats
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2650 - H2658.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X. Loyer, T. Damy, Z. Chvojkova, E. Robidel, F. Marotte, P. Oliviero, C. Heymes, and J.-L. Samuel
17{beta}-Estradiol Regulates Constitutive Nitric Oxide Synthase Expression Differentially in the Myocardium in Response to Pressure Overload
Endocrinology, October 1, 2007; 148(10): 4579 - 4584.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. Nadruz Jr, V. J. Lagosta, H. Moreno Jr, O. R. Coelho, and K. G. Franchini
Simvastatin Prevents Load-Induced Protein Tyrosine Nitration in Overloaded Hearts
Hypertension, May 1, 2004; 43(5): 1060 - 1066.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
I. Fleming
Brain in the Brawn: The Neuronal Nitric Oxide Synthase as a Regulator of Myogenic Tone
Circ. Res., October 3, 2003; 93(7): 586 - 588.
[Full Text] [PDF]